Medical Devices · Miami, Florida, United States
$0.68
-5.25% (-$0.04)2026-07-09
Smart-Money SignalNeutral · 50/100— Insiders are net buyers over 90 days ($343K, 11 buys vs 1 sale)
Revenue$3.4M
Net Income-$13.7M
EPS$-0.16
Gross Margin20.2%
Market Cap$32.0M
Price Performance
Historical data including institutional events
Company Profile
M
Marvin Slosman
CEO & Executive Director
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products to treat carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization. CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for flow reversal neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.
- Founded
- 2005
- Employees
- 66
- Headquarters
- Miami, Florida, United States
- Website
- www.inspiremd.com
Peer ComparisonRevenue ($B)
▾Loading company sections...